本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Enanta Pharmaceuticals Inc.

5.60
+0.10001.82%
盘后5.600.00000.00%18:24 EDT
成交量:14.01万
成交额:78.47万
市值:1.19亿
市盈率:-1.13
高:5.75
开:5.59
低:5.47
收:5.50
数据加载中...
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/10

重要事件披露

Form 8-K - Current report
2024/12/09

重要事件披露

Form 8-K - Current report
2024/11/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/15

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]